<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36586593</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>324</Volume><PubDate><Year>2023</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Cognitive impairments among patients in a long-COVID clinic: Prevalence, pattern and relation to illness severity, work function and quality of life.</ArticleTitle><Pagination><StartPage>162</StartPage><EndPage>169</EndPage><MedlinePgn>162-169</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2022.12.122</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-0327(22)01484-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">A considerable proportion of people experience lingering symptoms after Coronavirus Disease 2019 (COVID-19). The aim of this study was to investigate the frequency, pattern and functional implications of cognitive impairments in patients at a long-COVID clinic who were referred after hospitalisation with COVID-19 or by their general practitioner.</AbstractText><AbstractText Label="METHODS">Patients underwent cognitive screening and completed questionnaires regarding subjective cognition, work function and quality of life. Patients' cognitive performance was compared with that of 150 age-, sex-, and education-matched healthy controls (HC) and with their individually expected performance calculated based on their age, sex and education.</AbstractText><AbstractText Label="RESULTS">In total, 194 patients were assessed, on average 7&#xa0;months (standard deviation: 4) after acute COVID-19.44-53&#xa0;% of the patients displayed clinically relevant cognitive impairments compared to HC and to their expected performance, respectively. Moderate to large impairments were seen in global cognition and in working memory and executive function, while mild to moderate impairments occurred in verbal fluency, verbal learning and memory. Hospitalised (n&#xa0;=&#xa0;91) and non-hospitalised (n&#xa0;=&#xa0;103) patients showed similar degree of cognitive impairments in analyses adjusted for age and time since illness. Patients in the cognitively impaired group were older, more often hospitalised, had a higher BMI and more frequent asthma, and were more often female. More objective cognitive impairment was associated with more subjective cognitive difficulties, poorer work function and lower quality of life.</AbstractText><AbstractText Label="LIMITATIONS">The study was cross-sectional, which precludes causality inferences.</AbstractText><AbstractText Label="CONCLUSIONS">These findings underscore the need to assess and treat cognitive impairments in patients at long-COVID clinics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miskowiak</LastName><ForeName>K W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Copenhagen, &#xd8;ster Farimagsgade 2A, DK-1353 Copenhagen, Denmark; Neurocognition and Emotion in Affective Disorders (NEAD) Centre, Psychiatric Centre Copenhagen, Frederiksberg Hospital, DK-2000 Frederiksberg, Denmark. Electronic address: Kamilla.miskowiak@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Copenhagen, &#xd8;ster Farimagsgade 2A, DK-1353 Copenhagen, Denmark; Neurocognition and Emotion in Affective Disorders (NEAD) Centre, Psychiatric Centre Copenhagen, Frederiksberg Hospital, DK-2000 Frederiksberg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunnarsson</LastName><ForeName>D V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Department of Physio- and Occupational Therapy, Copenhagen University Hospital, Bispebjerg-Frederiksberg, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roikjer</LastName><ForeName>T K</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Copenhagen, &#xd8;ster Farimagsgade 2A, DK-1353 Copenhagen, Denmark; Neurocognition and Emotion in Affective Disorders (NEAD) Centre, Psychiatric Centre Copenhagen, Frederiksberg Hospital, DK-2000 Frederiksberg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podlekareva</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Respiratory Research Unit, Dept of Respiratory Medicine, Copenhagen University Hospital, Bispebjerg, Copenhagen, Denmark; Department of Respiratory Medicine, Copenhagen University Hospital at Bispebjerg, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Respiratory Research Unit, Dept of Respiratory Medicine, Copenhagen University Hospital, Bispebjerg, Copenhagen, Denmark; Respiratory Research Unit, Dept of Respiratory Medicine, Copenhagen University Hospital, Hvidovre, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dall</LastName><ForeName>C H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Physio- and Occupational Therapy, Copenhagen University Hospital, Bispebjerg-Frederiksberg, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnsen</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Respiratory Research Unit, Dept of Respiratory Medicine, Copenhagen University Hospital, Bispebjerg, Copenhagen, Denmark; Department of Respiratory Medicine, Copenhagen University Hospital at Bispebjerg, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="Y">Cognition Disorders</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Work function</Keyword></KeywordList><CoiStatement>Conflict of interest The authors report no conflicts of interest in relation to the current manuscript. Outside of the present work, KWM reports having received consultancy fees from Janssen-Cilag and Lundbeck; JKP, DVG, DP, HH, CHD and SJ report no conflicts of interest outside of the present work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>31</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36586593</ArticleId><ArticleId IdType="pmc">PMC9795797</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2022.12.122</ArticleId><ArticleId IdType="pii">S0165-0327(22)01484-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Albu S., Zozaya N.Rivas, Murillo N., Garcia-Molina A., Chacon C.A.Figueroa, Kumru H. Multidisciplinary outpatient rehabilitation of physical and neurological sequelae and persistent symptoms of covid-19: a prospective, observational cohort study. Disabil. Rehabil. 2021:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34559592</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemanno F., Houdayer E., Parma A., Spina A., Del Forno A., Scatolini A., Angelone S., Brugliera L., Tettamanti A., Beretta L., Iannaccone S. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Alnefeesi Y., Siegel A., Lui L.M.W., Teopiz K.M., Ho R.C.M., Lee Y., Nasri F., Gill H., Lin K., Cao B., Rosenblat J.D., McIntyre R.S. Impact of SARS-CoV-2 infection on cognitive function: a systematic review. Front Psychiatry. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7902710</ArticleId><ArticleId IdType="pubmed">33643083</ArticleId></ArticleIdList></Reference><Reference><Citation>Attix D.K., Story T.J., Chelune G.J., Ball J.D., Stutts M.L., Hart R.P., Barth J.T. The prediction of change: normative neuropsychological trajectories. Clin. Neuropsychol. 2009;23:21&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">18720272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey Erin K., Steward Kayla A., VandenBussche Jantz Alicia B., Kamper Joel E., Mahoney Elaine J., Duchnick Jennifer J. Neuropsychology of COVID-19: anticipated cognitive and mental health outcomes. Neuropsychology. 2021;35:335&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">34043385</ArticleId></ArticleIdList></Reference><Reference><Citation>Battery Army Individual Testcollab. War Department, Adjutant General&#x2019;s Office; Washington, DC: 1944. Manual of Directions and Scoring.</Citation></Reference><Reference><Citation>Bliddal S., Banasik K., Pedersen O.B., Nissen J., Cantwell L., Schwinn M., Tulstrup M., Westergaard D., Ullum H., Brunak S., Tommerup N., Feenstra B., Geller F., Ostrowski S.R., Gronbaek K., Nielsen C.H., Nielsen S.D., Feldt-Rasmussen U. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci. Rep. 2021;11:13153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini Maura, Canoll Peter D., Klein Robyn S. How COVID-19 Affects the brain. JAMA Psychiatry (Chicago, Ill.) 2021;78:682&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent D.E., Cooper P.F., FitzGerald P., Parkes K.R. The cognitive failures questionnaire (CFQ) and its correlates. Br. J. Clin. Psychol. 1982;21:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">7126941</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungenberg J., Humkamp K., Hohenfeld C., Rust M.I., Ermis U., Dreher M., Hartmann N.K., Marx G., Binkofski F., Finke C., Schulz J.B., Costa A.S., Reetz K. Long COVID-19: objectifying most self-reported neurological symptoms. Ann. Clin. Transl. Neurol. 2022;9:141&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862437</ArticleId><ArticleId IdType="pubmed">35060361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., Lin K., Mansur R.B., Ho R.C., Rosenblat J.D., Miskowiak K.W., Vinberg M., Maletic V., McIntyre R.S. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Costas-Carrera A., Sanchez-Rodriguez M.M., Canizares S., Ojeda A., Martin-Villalba I., Prime-Tous M., Rodriguez-Rey M.A., Segu X., Valdesoiro-Pulido F., Borras R., Peri J.M., Vieta E. Neuropsychological functioning in post-ICU patients after severe COVID-19 infection: the role of cognitive reserve. Brain Behav. Immun. Health. 2022;21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8818554</ArticleId><ArticleId IdType="pubmed">35156065</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. The mystery of the pandemic's 'happy hypoxia. Science. 2020;368:455&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">32355007</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L., Calandri I., Corvalan N., Carello M.A., Keller G., Martinez C., Arruabarrena M., Allegri R. Cognitive consequences of COVID-19: results of a cohort study from South America. Arq. Neuropsiquiatr. 2022;80:240&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9648931</ArticleId><ArticleId IdType="pubmed">34816972</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., Jbabdi S., Taschler B., Keating P., Winkler A.M., Collins R., Matthews P.M., Allen N., Miller K.L., Nichols T.E., Smith S.M. SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature. 2022;604:697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Duff K. Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods. Arch. Clin. Neuropsychol. 2012;27:248&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3499091</ArticleId><ArticleId IdType="pubmed">22382384</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenreich Hannelore, Weissenborn Karin, Begemann Martin, Busch Markus, Vieta Eduard, Miskowiak Kamilla W. Erythropoietin as candidate for supportive treatment of severe COVID-19. Mol. Med. (Cambridge, Mass.) 2020;26 58-58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7297268</ArticleId><ArticleId IdType="pubmed">32546125</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Molina A., Tormos J.M., Bernabeu M., Junque C., Roig-Rovira T. Do traditional executive measures tell us anything about daily-life functioning after traumatic brain injury in spanish-speaking individuals? Brain Inj. 2012;26:864&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pubmed">22583177</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouraud C., Bottemanne H., Lahlou-Laforet K., Blanchard A., Gunther S., Batti S.E., Auclin E., Limosin F., Hulot J.S., Lebeaux D., Lemogne C. Association between psychological distress, cognitive complaints, and neuropsychological status after a severe COVID-19 episode: a cross-sectional study. Front Psychiatry. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8446522</ArticleId><ArticleId IdType="pubmed">34539470</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire Adam, Trender William, Chamberlain Samuel R., Jolly Amy, Grant Jon E., Patrick Fiona, Mazibuko Ndaba, Williams Steve, Barnby Joseph M., Hellyer Peter, Mehta Mitul A. medRxiv: 2020.10.20.20215863; 2020. Cognitive Deficits in People Who Have Recovered From COVID-19 Relative to Controls: An N=84,285 Online Study.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt Kelsey C., Marra David E., Block Cady, Cysique Lucette A., Drane Daniel L., Haddad Michelle M., &#x141;ojek Emilia, McDonald Carrie R., Reyes Anny, Eversole Kara, Bowers Dawn. Central nervous system manifestations of COVID-19: a critical review and proposed research agenda. J. Int. Neuropsychol. Soc. 2022;28:311&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10035233</ArticleId><ArticleId IdType="pubmed">33858556</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A., Vanderlind W.M., Alexopoulos G.S., Fridman C.B., Perlis R.H., Gunning F.M. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021;46:2235&#x2013;2240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen J.H., Stottrup M.M., Nayberg E., Knorr U., Ullum H., Purdon S.E., Kessing L.V., Miskowiak K.W. Optimising screening for cognitive dysfunction in bipolar disorder: validation and evaluation of objective and subjective tools. J. Affect. Disord. 2015;187:10&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">26301477</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan K., Miller A.K., Reiter K., Bonner-Jackson A. Neurocognitive profiles in patients with persisting cognitive symptoms associated with COVID-19. Arch. Clin. Neuropsychol. 2022;37(4):729&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903427</ArticleId><ArticleId IdType="pubmed">35136912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lersy F., Benotmane I., Helms J., Collange O., Schenck M., Brisset J.C., Chammas A., Willaume T., Lefebvre N., Solis M., Hansmann Y., Fabacher T., Caillard S., Mertes P.M., Pottecher J., Schneider F., Meziani F., Fafi-Kremer S., Kremer S. Cerebrospinal fluid features in patients with coronavirus disease 2019 and neurological manifestations: correlation with brain magnetic resonance imaging findings in 58 patients. J. Infect. Dis. 2021;223:600&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7798956</ArticleId><ArticleId IdType="pubmed">33249438</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd A., Pickard A.S. The EQ-5D and the EuroQol group. Value Health. 2019;22:21&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">30661629</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Res. Sq. 2021 rs.3. rs-266574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattioli F., Piva S., Stampatori C., Righetti F., Mega I., Peli E., Sala E., Tomasi C., Indelicato A.M., Latronico N., De Palma G. Neurologic and cognitive sequelae after SARS-CoV2 infection: different impairment for ICU patients. J. Neurol. Sci. 2022;432</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8620095</ArticleId><ArticleId IdType="pubmed">34894422</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattioli F., Stampatori C., Righetti F., Sala E., Tomasi C., De Palma G. Neurological and cognitive sequelae of Covid-19: a four month follow-up. J. Neurol. 2021;268:4422&#x2013;4428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8088203</ArticleId><ArticleId IdType="pubmed">33932157</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza Mario Gennaro, Palladini Mariagrazia, De Lorenzo Rebecca, Magnaghi Cristiano, Poletti Sara, Furlan Roberto, Ciceri Fabio, Rovere-Querini Patrizia, Benedetti Francesco. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez R., Balanza-Martinez V., Luperdi S.C., Estrada I., Latorre A., Gonzalez-Jimenez P., Feced L., Bouzas L., Yepez K., Ferrando A., Hervas D., Zaldivar E., Reyes S., Berk M., Menendez R. Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J. Intern. Med. 2021;290:621&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Fugledalen L., Jespersen A.E., Sattler S.M., Podlekareva D., Rungby J., Porsberg C.M., Johnsen S. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: pattern, severity, and functional implications. Eur. Neuropsychopharmacol. 2022;59:82&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9008126</ArticleId><ArticleId IdType="pubmed">35561540</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Johnsen S., Sattler S.M., Nielsen S., Kunalan K., Rungby J., Lapperre T., Porsberg C.M. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur. Neuropsychopharmacol. 2021;46:39&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V., Fonsmark L., Christensen R.H.B., Amiri M., Merie C., Lebech A.M., Katzenstein T., Bang L.E., Kjaergaard J., Kondziella D., Benros M.E. Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for non-COVID-19 illness. JAMA Psychiatry. 2022;79(5):486&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943626</ArticleId><ArticleId IdType="pubmed">35319743</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen S.L., Ludwigsen T., Johnsen S., Miskowiak K.W. Cognitive late sequelae of COVID-19. Ugeskr. Laeger. 2022;184</Citation><ArticleIdList><ArticleId IdType="pubmed">35410644</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  Technical article: updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021. 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021</Citation></Reference><Reference><Citation>Ott C.V., Knorr U., Jespersen A., Obenhausen K., Roen I., Purdon S.E., Kessing L.V., Miskowiak K.W. Norms for the screen for cognitive impairment in psychiatry and cognitive trajectories in bipolar disorder. J. Affect. Disord. 2021;281:33&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">33285390</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott Caroline V., Vinberg Maj, Kessing Lars V., Bowie Christopher R., Forman Julie L., Miskowiak Kamilla W. Effect of action-based cognitive remediation on cognitive impairment in patients with remitted bipolar disorder: a randomized controlled trial. Bipolar Disord. 2021;23:487&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pubmed">33053258</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti S., Palladini M., Mazza M.G., Lorenzo R.De, Covid- BioB Outpatient Clinic Study group. Furlan R., Ciceri F., Rovere-Querini P., Benedetti F. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur. Arch. Psychiatry Clin. Neurosci. 2021;272(5):773&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546751</ArticleId><ArticleId IdType="pubmed">34698871</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi A.I., Baskett W.I., Huang W., Naqvi S.H., Shyu C.R. New-onset dementia among survivors of pneumonia associated with severe acute respiratory syndrome coronavirus 2 infection. Open Forum Infect. Dis. 2022;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903511</ArticleId><ArticleId IdType="pubmed">35350170</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly M.C., Zbrozek A.S., Dukes E.M. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4:353&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">10146874</ArticleId></ArticleIdList></Reference><Reference><Citation>Statens Serum Institut  Beskrivelse af udvalgte virusvarianter. 2022. https://covid19.ssi.dk/virusvarianter/virusvariantbeskrivelser</Citation></Reference><Reference><Citation>Sylvester S.V., Rusu R., Chan B., Bellows M., O'Keefe C., Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr. Med. Res. Opin. 2022;38:1391&#x2013;1399.</Citation><ArticleIdList><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet Maxime, Sillett Rebecca, Zhu Lena, Mendel Jacob, Camplisson Isabella, Dercon Quentin, Harrison Paul J. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside D.M., Basso M.R., Naini S.M., Porter J., Holker E., Waldron E.J., Melnik T.E., Niskanen N., Taylor S.E. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection part 1: cognitive functioning. Clin. Neuropsychol. 2022:1&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35130818</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>